AGP Franklin LLC bought a new position in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 5,840 shares of the medical research company’s stock, valued at approximately $795,000.
A number of other large investors have also added to or reduced their stakes in the business. Brighton Jones LLC raised its position in shares of Agilent Technologies by 6.1% in the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after purchasing an additional 270 shares during the period. Jones Financial Companies Lllp lifted its stake in shares of Agilent Technologies by 15.9% during the 1st quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock worth $602,000 after buying an additional 769 shares during the last quarter. Geneos Wealth Management Inc. boosted its holdings in shares of Agilent Technologies by 54.8% during the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock worth $70,000 after buying an additional 212 shares during the period. Acadian Asset Management LLC boosted its holdings in shares of Agilent Technologies by 16.5% during the 1st quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock worth $625,000 after buying an additional 758 shares during the period. Finally, Sivia Capital Partners LLC acquired a new position in Agilent Technologies in the 2nd quarter valued at about $273,000.
Analysts Set New Price Targets
Several equities research analysts have issued reports on the stock. HSBC assumed coverage on shares of Agilent Technologies in a research report on Tuesday, January 20th. They set a “buy” rating and a $180.00 price objective for the company. UBS Group lowered their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. TD Cowen dropped their price target on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Morgan Stanley reduced their price target on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, March 3rd. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Agilent Technologies in a report on Monday, December 29th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $163.71.
Agilent Technologies Trading Down 5.1%
Shares of A stock opened at $114.32 on Friday. The stock has a market cap of $32.31 billion, a P/E ratio of 25.24, a price-to-earnings-growth ratio of 2.54 and a beta of 1.30. Agilent Technologies, Inc. has a 1 year low of $103.16 and a 1 year high of $160.27. The company has a current ratio of 2.07, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44. The stock has a 50 day simple moving average of $117.45 and a 200 day simple moving average of $133.40.
Agilent Technologies (NYSE:A – Get Free Report) last posted its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The company had revenue of $1.80 billion for the quarter, compared to the consensus estimate of $1.81 billion. During the same quarter last year, the business earned $1.31 EPS. Agilent Technologies’s revenue was up 7.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, research analysts predict that Agilent Technologies, Inc. will post 5.95 earnings per share for the current fiscal year.
Agilent Technologies Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st were paid a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date was Tuesday, March 31st. Agilent Technologies’s dividend payout ratio is presently 22.52%.
Agilent Technologies Company Profile
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Recommended Stories
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
